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Short summary 
Rationale, aims and objectives: As government-funded healthcare provisions are stretched to 
their limits, it is important that healthcare professionals provide evidence-based advice about 
minor ailments to facilitate people to self-treat these effectively and appropriately. 
Unfortunately, despite the expanding over-the-counter (OTC) medicines market, there have 
been doubts cast about advice given by UK community pharmacists. Indeed, research 
conducted with pharmacists revealed that evidence of effectiveness was a secondary 
consideration when making decisions about OTC recommendations. We aimed to address these 
concerns and support decision-making by providing high quality, evidence-based, information 
about self-treatable conditions and over-the-counter consultations through a mobile phone app. 
Method: There were four main stages, namely: app development (content and design); piloting 
(use-testing); publication on Apple and Android stores and marketing of the app, and finally 
an evaluation (using analytical data obtained through the app content management system, 
feedback obtained via email, the star-rating and reviews posted on Google Play and Apple 
stores, and comments obtained at events. Additionally, following ethical approval and piloting, 
we invited one hundred people representing different groups within the pharmacy profession 
in Northern Ireland to complete an evaluation questionnaire). 
Results: Since launching in February 2017, there have been over 2726 downloads, 34491 
sessions of use, and it has received a 5-star rating on both Apple and Google Play stores. 
Positive feedback has centred on the material being relevant and up-to-date, that it facilitates 
quick access to information in the workplace and is easy to navigate, and is a good training 
tool. Future suggestions for improvement include expanding the number of conditions and 
providing self-assessment questions to help students prepare for professional examinations. 
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Conclusions: The app appears to have had a positive impact on OTC consultations but it is still 
evolving to ensure its usefulness in practice is maximised. 
Introduction 
In 2014, there were 3.7 million visits to Accident and Emergency (A&E) hospital departments 
for self-treatable conditions, at a cost of £290 million to the National Health Service (NHS) (1). 
Furthermore, around 57 million general practitioner (GP) appointments per annum are for self-
treatable conditions, costing the NHS £2 billion (1). As NHS resources are stretched to their 
limits, it is important that healthcare professionals provide evidence-based advice about minor 
ailments to facilitate people to self-treat these effectively and appropriately. Many over-the 
counter (OTC) medicines to treat such ailments are available in community pharmacies across 
the United Kingdom (UK); this market continues to expand with three further prescription-
only deregulations in July 2017 (2). Indeed, in the UK in November 2017, sildenafil (Viagra 
Connect®) was deregulated from prescription-only status for men aged 18 years and over for 
erectile dysfunction (3); the UK is the first country in the world to approve this deregulation (3). 
 
Unfortunately, there have been doubts cast about advice given by UK community pharmacists 
and research conducted with pharmacists revealed that evidence of effectiveness was a 
secondary consideration when making decisions about OTC recommendations (4-9). We sought 
to address these concerns and support decision-making by providing high quality information 
through a mobile phone app. Many medical apps make mobile devices valuable tools within 
healthcare education to aid clinical decision-making and knowledge-base at the point of care, 
and have been shown to have positive effects on patient outcomes including reducing adverse 
events and length of stay in hospital (10,11). 
 
4 
 
It was anticipated that our app could enable the public to receive best practice management 
strategies for self-treatable conditions, leading to increased satisfaction and positive healthcare 
outcomes (whilst reducing the amount of time and money wasted on inappropriate options). It 
also had the potential to improve standardisation of care. It is relevant to any healthcare 
professional who provides advice to patients about self-treatable conditions. To the best of the 
authors’ knowledge, there are no similar apps available that directly relate to OTC 
consultations (12,13). While information is published by providers such as the National Institute 
for Health and Care Excellence (NICE) and in textbooks, it is either not specifically tailored 
for pharmacy use, for example, it doesn’t take into account marketing authorisations of over-
the-counter medicines, or quickly goes out of date. 
 
The aim was to publish an app in the Apple and Google Play stores that provides evidence-
based clinical information on OTC medicines and self-treatable conditions.  
The objectives were to: 
1. Search and critically evaluate the literature for information pertaining to the OTC 
treatment of self-treatable conditions; 
2. Produce summaries for conditions with management strategies encompassing 
pharmacological and non-pharmacological advice; 
3. Design an attractive app interface that allows rapid navigation to the information (and 
functionality that enables amendments and updates to reach the downloaded app)  
 
Methods and materials 
A Gantt chart was prepared for the bursary application; work on the app started in June 2016 
with a proposed publication deadline of the end of January 2017. Six months following 
publication, an evaluation was conducted. 
5 
 
 
Development of content involved a literature search and critical analysis of material in terms 
of its relevance to OTC consultations. Key therapeutic areas investigated were: children’s 
health; eye and ear; gastrointestinal conditions; musculoskeletal conditions; nervous system; 
respiratory conditions; skin conditions; skin infections; travel health and women’s and men’s 
health. These ten areas were then further sub-divided to encompass minor ailments/conditions 
within each (for example, within the therapeutic area ‘respiratory conditions’ are: acute 
sinusitis, allergic rhinitis, sore throat, cough, common cold and influenza). The main headings 
for each condition were: clinical features, referral criteria, time frame to resolution, and a 
management strategy (non-pharmacological and pharmacological advice). Resources used to 
populate the app content included Cochrane Systematic Reviews, relevant Medicine and 
Healthcare products Regulatory Agency (MHRA) medicine safety announcements, the 
Electronic Medicines Compendium (i.e. the Summary of Product Characteristics and Patient 
Information Leaflets relating to specific OTC products), the National Institute for Health and 
Care Excellence (NICE) pathways and NICE Clinical Knowledge Summaries (CKS), the 
Faculty of Sexual and Reproductive Healthcare (FSRH), and other reputable organisations such 
as Travel Health Pro.  
 
In terms of app creation, the bursary obtained was used to pay Bluemonkee™ Digital to support 
us to publish the app. The experienced developer prepared one condition and provided training 
on the content management system (CMS) to enable the authors to design the remainder (over 
seventy individual conditions). This required the authors to independently gain expertise in 
graphic design and to become familiar with HyperText Markup Language (HTML) and 
produce the app name. 
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The content was peer reviewed by colleagues who had expertise in the area of OTC medicines. 
The pilot (use testing) involved registered pharmacists and postgraduate pharmacist PhD 
students with Apple and Android devices. Feedback centred on including some photographs to 
aid with diagnosis of certain conditions, therefore stock images were purchased and a photo 
gallery created. More information on recently deregulated prescription-only medicines was 
wanted, so a separate section relating to these medicines was prepared. Some pilot participants 
desired health promotion advice, so we added the UK vaccination schedule, UK adult screening 
programmes and information about staying off nursery and school in relation to various 
infectious conditions. The original name was changed to enable the app to be found more easily 
in the App stores. 
 
Once it was published on Google Play and Apple stores in February 2017 (free of charge to 
download), we marketed it by approaching popular UK pharmacy publications, had Facebook 
coverage, attended a digital literacies conference, and exhibited the app at a healthcare 
‘Inspiring Change’ event. Currently is has been shortlisted for an ‘E-Health and Innovation 
Award’ (winners will be announced on 27th January 2018 at a prestigious event) which has 
resulted in indirect publicity since the awards event being hosted by a UK television celebrity.  
 
Six months after publication, a multi-faceted evaluation of the app was conducted. Quantitative 
data was obtained through the CMS. Feedback was also obtained via email, the star-rating and 
reviews posted on Google Play and Apple stores, and comments at the conference and event. 
[The push notification function failed as a method of communication due to an unresolved 
technical issue]. Additionally, following ethical approval (reference number: 017PMY2017), 
we invited one hundred people representing different groups within the pharmacy profession 
in Northern Ireland (pharmacy undergraduate students, pharmacy graduates who were 
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undertaking their compulsory placement year prior to registration/licensing, and community 
pharmacists) by email or letter to complete an evaluation questionnaire. The authors had access 
to students’ and graduates’ university email addresses, so a random sample of these cohorts 
was emailed (20 final year undergraduate pharmacy students who were currently learning about 
over-the-counter consultations and 30 graduates undertaking their compulsory placement year 
in community pharmacy practice). To access the pharmacists, 50 addresses from the list of 
registered NI community pharmacies10 were randomly selected and invitations and 
questionnaires posted to them (addressed to ‘The Pharmacist’, with a pre-paid return envelope 
included). The short evaluation questionnaire had four questions with several parts to each 
(largely closed-type) and is available on request from the corresponding author. It largely 
focussed on what they liked and did not like about the app including rating its usefulness in 
practice. Respondents who had never used the app before were asked to explain why this was 
the case and also asked to download the app so that they could provide feedback about it. To 
enhance the response rate (14), a reminder email was sent to all undergraduate and graduate 
students (and a reminder letter with pre-paid envelope was sent to the same random selection 
of pharmacies) with a statement to ignore the invitation if they had already participated. The 
responses from the completed questionnaires were coded and entered into a customized 
database developed on IBM SPSS v22 (SPSS Inc., Chicago, IL) for statistical analysis. Data 
analysis largely took the form of descriptive statistics and key themes were derived from the 
qualitative free-response comments (thematic analysis) (15). 
 
Results 
Since launch of the app in February 2017, the analytics from the CMS are: 
 Downloads: 2011 (Apple); 715 (Android)   
 Sessions: 25213 (Apple); 9278 (Android) 
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 Average session length: 2.5 minutes (Apple); 2.4 minutes (Android) 
 Top 10 user locations (by session numbers): UK, Ireland, US, Egypt, Saudi Arabia, 
Hong Kong, Malaysia, Australia, Iran and Netherlands. 
It has a 5-star rating on Google Play and Apple stores; examples of user reviews (posted on 
Google Play and Apple stores) are: 
 “A really useful app…easy to navigate and it’s great that it's so up to date. Have already used 
it with our technicians in a training session...”  
“…a super app which is very focussed on supporting pharmacists and the pharmacy team to 
provide evidence-based and complete patient care.”  
 “…a great help.” 
 
Questionnaire: a 27% response rate was obtained. Mean score for ‘usefulness in practice’ (1 
‘not useful’ to 5 ‘very useful’) = 4.1. Only one respondent stated that he/she could not 
download the app or provide feedback on it as he/she did not have an android or apple device. 
 
Overall summary of positive and negative aspects (from the evaluation questionnaire free-
response questions and other qualitative feedback): 
Positive aspects: quirky design (particularly avatars); easy to navigate; facilitates quick access 
to information; information is evidence-based, up-to-date, and relevant; good staff training tool 
(particularly the photo gallery). 
Negative aspects: requires internet access, limited search capabilities; would like more 
conditions and medicines to be covered and a section relating to self-assessment. 
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Discussion 
The app appears to have had a positive impact on OTC consultations. Despite a steep learning 
curve and time-intensive process, developing it was rewarding and the authors look forward to 
enhancing it in the future. The authors hope that this paper encourages others to consider 
undertaking a similar project. The key findings are similar to those reported elsewhere in 
relation to usefulness as an educational tool at undergraduate level for medical and pharmacy 
students (16-18) and to support clinical decision-making in practice (19-23). 
 
It must be noted that the response rate to the evaluation questionnaire was low, risking non-
response bias. However, this was only one aspect of the overall app evaluation. Moreover, 
some data (such as locations) are only gathered in the CMS if users have enabled particular 
settings on their phones. While the overall project aim was met (to publish an app in the Apple 
and Google Play stores that provides evidence-based clinical information on OTC medicines 
and self-treatable conditions), we do not know whether patient outcomes have improved. 
 
Future improvements to the app will include expanding the number of conditions, providing 
some pertinent information on complementary and alternative medicines (such as the evidence-
base for common therapies, including effectiveness and safety data), and self-assessment 
questions to help students prepare for professional examinations. We are investigating ways 
that allow the data to be stored locally, and strive for better push notification and search 
functionality. However, storing the data locally means that users would not obtain any changes 
automatically as is currently the case (i.e. the onus would be on the user to ensure they had 
done the required app updates). Engagement and functionality could be enhanced by including 
relevant stakeholders in discussions about future developments. 
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Conclusion 
Following the launch in February 2017, this mobile phone app has been well received as a 
valuable tool to support and enhance patient care with regard to self-treatable conditions. The 
app has relevance to any healthcare professional who provides advice to patients about such 
conditions and the work should be of value to those interested in developing educational mobile 
phone applications. Marketing of the app has been successful to some degree as determined by 
the number of downloads, but more could be done to publicise the app within and beyond the 
pharmacy profession. In addition to use-testing prior to the launch onto Apple and Google 
stores, conducting a post-launch evaluation was a worthwhile exercise. The evaluation data 
revealed that the app has many positive features with the collation of contemporary information 
from numerous evidence-based resources facilitating decision-making at the point of care. 
However, several ways that the app could be adapted to maximise its usefulness have also been 
exposed. The time commitment for this work should not be underestimated, both in the 
development stage prior to launch and thereafter. Due to the dynamic nature of the clinical 
subject material, a strategy about maintaining and enhancing the content is required, coupled 
with an ongoing commitment to make ad hoc changes as necessary to mirror changes in 
practice and meet the needs of relevant stakeholders.  
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